Cerus Corporation (CERS): Price and Financial Metrics

Cerus Corporation (CERS)

Today's Latest Price: $6.83 USD

0.17 (-2.43%)

Updated Jul 10 4:00pm

Add CERS to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 338 in Biotech

See all "A" rated Strong Buy stocks

CERS Stock Summary

  • Of note is the ratio of Cerus Corp's sales and general administrative expense to its total operating expenses; 28.63% of US stocks have a lower such ratio.
  • CERS's price/sales ratio is 11.61; that's higher than the P/S ratio of 88.64% of US stocks.
  • As for revenue growth, note that CERS's revenue has grown 19.08% over the past 12 months; that beats the revenue growth of 77.89% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to Cerus Corp, a group of peers worth examining would be PSNL, JG, KIN, MRAM, and CTIC.
  • CERS's SEC filings can be seen here. And to visit Cerus Corp's official web site, go to www.cerus.com.
CERS Daily Price Range
CERS 52-Week Price Range

CERS Stock Price Chart Technical Analysis Charts

CERS Price/Volume Stats

Current price $6.83 52-week high $7.49
Prev. close $7.00 52-week low $2.71
Day low $6.82 Volume 1,357,270
Day high $7.00 Avg. volume 1,985,806
50-day MA $6.10 Dividend yield N/A
200-day MA $4.93 Market Cap 1.12B

Cerus Corporation (CERS) Company Bio

Cerus Corporation operates as a biomedical products company which focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company was founded in 1991 and is based in Concord, California.

CERS Latest News Stream

Event/TimeNews Detail
Loading, please wait...

CERS Latest Social Stream

Loading social stream, please wait...

View Full CERS Social Stream

Latest CERS News From Around the Web

Below are the latest news stories about Cerus Corp that investors may wish to consider to help them evaluate CERS as an investment opportunity.

Cerus Intercept Blood System inactivates SARS-CoV-2 in plasma

Cerus (CERS) announces study results that showed the complete inactivation of the SARS-CoV-2 virus in plasma components intended for transfusion via the use of its INTERCEPT Blood System, a device used by blood banks to reduce the risk of transfusion-transmitted infections from a range of pathogens in platelets, plasma and...

Seeking Alpha | July 7, 2020

Cerus Corporation Reports Successful Inactivation of SARS-CoV-2 with the INTERCEPT Blood System for Plasma

Cerus Corporation (Nasdaq:CERS) announced today study results demonstrating that the INTERCEPT Blood System inactivates SARS-CoV-2, the causative agent for COVID-19, in plasma components intended for transfusion. These data are consistent with prior INTERCEPT studies showing complete inactivation, to below the limit of detection, of other coronaviruses associated with severe pulmonary disease: MERS-CoV1,2 (2018, 2019) and SARS-CoV-13 (2005).

Yahoo | July 7, 2020

What Kind Of Shareholders Hold The Majority In Cerus Corporation's (NASDAQ:CERS) Shares?

Every investor in Cerus Corporation (NASDAQ:CERS) should be aware of the most powerful shareholder groups. Large...

Yahoo | July 6, 2020

Cerus Corporation (CERS): Hedge Funds Getting Bullish

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F […]

Yahoo | June 24, 2020

Is Cerus (CERS) Outperforming Other Medical Stocks This Year?

Is (CERS) Outperforming Other Medical Stocks This Year?

Yahoo | June 17, 2020

Read More 'CERS' Stories Here

CERS Price Returns

1-mo 21.96%
3-mo N/A
6-mo 58.47%
1-year 23.96%
3-year 200.88%
5-year 28.87%
YTD 61.85%
2019 -16.77%
2018 50.00%
2017 -22.30%
2016 -31.17%
2015 1.28%

Continue Researching CERS

Want to see what other sources are saying about Cerus Corp's financials and stock price? Try the links below:

Cerus Corp (CERS) Stock Price | Nasdaq
Cerus Corp (CERS) Stock Quote, History and News - Yahoo Finance
Cerus Corp (CERS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.9238 seconds.